Long-term follow-up of treatment-naïve HBeAg-negative patients with chronic hepatitis B

被引：0
|
作者：
Yusuf Emre Ozdemir
Meryem Sahin Ozdemir
Osman Faruk Bayramlar
Serkan Surme
Sibel Yildiz Kaya
Ridvan Karaali
Ilker Inanc Balkan
Bilgul Mete
Nese Saltoglu
Fehmi Tabak
机构：
[1] Istanbul University-Cerrahpasa,Department of Infectious Diseases and Clinical Microbiology, Cerrahpasa Faculty of Medicine
[2] Istanbul Provincial Health Directorate,Department of Public Health
来源：
Irish Journal of Medical Science (1971 -) | 2023年 / 192卷
关键词：
Antiviral agents; Chronic hepatitis B; Entecavir; Lamivudine; Tenofovir disoproxil fumarate; Virological response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：633 / 639
页数：6
相关论文
共 50 条
  • [31] The long-term effects of lamivudine treatment in patients with HBeAg-negative liver cirrhosis
    Z. Mesut Yalin Kilic
    Sedef Kuran
    Meral Akdogan
    Bahattin Cicek
    Dilek Oguz
    Bulent Odemis
    Nurgul Sasmaz
    Advances in Therapy, 2008, 25 : 190 - 200
  • [32] Efficacy of Real-world Entecavir Therapy in Treatment-na?ve Chronic Hepatitis B Patients
    Xie Yan-Di
    Ma Hui
    Feng Bo
    Wei Lai
    中华医学杂志英文版, 2017, 130 (18) : 2190 - 2197
  • [33] Ultra-Long-term Follow-up of Interferon Alfa Treatment for HBeAg-Positive Chronic Hepatitis B Virus Infection
    Choi, Hannah S. J.
    van Campenhout, Margo J. H.
    van Vuuren, Anneke J.
    Krassenburg, Lisette A. P.
    Sonneveld, Milan J.
    de Knegt, Robert J.
    Hansen, Bettina E.
    Janssen, Harry L. A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (09) : 1933 - +
  • [34] The long-term effects of lamivudine treatment in patients with HBeAg-negative liver cirrhosis
    Kilic, Z. Mesut Yalin
    Kuran, Sedef
    Akdogan, Meral
    Cicek, Bahattin
    Oguz, Dilek
    Odemis, Bulent
    Sasmaz, Nurgul
    ADVANCES IN THERAPY, 2008, 25 (03) : 190 - 200
  • [35] Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: The case for continuous antiviral therapy
    Shouval, Daniel
    Lai, Ching-Lung
    Chang, Ting-Tsung
    Cheinquer, Hugo
    Martin, Paul
    Carosi, Glamplero
    Han, Steven
    Kaymakoglu, Sabahattin
    Tamez, Ricardo
    Yang, Joanna
    Tenney, Daniel
    Brett-Smith, Helena
    JOURNAL OF HEPATOLOGY, 2009, 50 (02) : 289 - 295
  • [36] Efficacy and Safety of Tenofovir Disoproxil Fumarate in Treatment-Naïve Patients with Chronic Hepatitis B in Korea
    Jung Hyun Kwon
    Myeong Jun Song
    Jeong Won Jang
    Si Hyun Bae
    Jong Young Choi
    Seung Kew Yoon
    Hee Yeon Kim
    Chang Wook Kim
    Do Seon Song
    U. Im Chang
    Jin Mo Yang
    Chan Ran You
    Sang Wook Choi
    Hae Lim Lee
    Sung Won Lee
    Nam Ik Han
    Soon Woo Nam
    Sang Gyune Kim
    Young Seok Kim
    Seok Hyun Kim
    Byung Seok Lee
    Tae Hee Lee
    Eun-Young Cho
    Digestive Diseases and Sciences, 2019, 64 : 2039 - 2048
  • [37] Clinical Experience with Long-term Lamivudine Therapy to Determine the Adequate Duration of Treatment in Children and Adolescents with HBeAg-Negative Chronic Hepatitis B
    Kim, Jung-Mi
    Hong, Suk Jin
    Choi, Byung-Ho
    Chu, Mi Ae
    Cho, Seung Man
    Choe, Byung-Ho
    PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2009, 12 (01) : 23 - 29
  • [38] Predictors of HBsAg Seroclearance in HBeAg-Negative Chronic Hepatitis B Patients
    Kwak, Min-Sun
    Cho, Eun Ju
    Jang, Eun Sun
    Lee, Jeong-Hoon
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Hyo-Suk
    DIGESTION, 2011, 84 : 23 - 28
  • [39] Relationship between serum b2-microglobulin levels and virological breakthrough in HBeAg-negative chronic hepatitis B patients, under long-term treatment schedules including lamivudine
    Elefsiniotis, Ioannis S.
    Moulakakis, Antonios
    Pantazis, Konstantinos D.
    Glynou, Irene
    Ketikoglou, Ioannis
    Vezali, Elena
    Kada, Helen
    Tsianos, Epameinondas
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (13) : 1922 - 1928
  • [40] Relationship between serum b2-microglobulin levels and virological breakthrough in HBeAg-negative chronic hepatitis B patients,under long-term treatment schedules including lamivudine
    Ioannis S.Elefsiniotis
    Antonios Moulakakis
    Konstantinos D.Pantazis
    Irene Glynou
    Ioannis Ketikoglou
    Elena Vezali
    Helen Kada
    Epameinondas Tsianos
    World Journal of Gastroenterology, 2005, (13) : 1922 - 1928
12345